Warnings and Precautions for Using Dapagliflozin

Dapagliflozin (Dapagliflozin) is an oral drug that belongs to the sodium glucose co-transporter 2 (SGLT2) inhibitor drug class. It is mainly used to treat 2 type diabetes. It lowers blood sugar levels by reducing the reabsorption of glucose by the kidneys and promoting the excretion of glucose in the urine. However, there are some warnings and precautions to be aware of when using dapagliflozin to ensure safe and effective treatment.

Warning:

1.Risk of ketoacidosis: The use of dapagliflozin may increase the risk of ketoacidosis. During treatment, patients should pay attention to monitoring blood sugar levels and avoid excessive hunger or strenuous exercise to reduce the risk of ketoacidosis.

2.Severe urinary tract infection: Use of dapagliflozin may cause urinary tract infection, including pyelonephritis. Patients should practice good hygiene, seek prompt medical treatment for any infection, and follow their doctor's advice.

3.Risk of hypoglycemia: Dapagliflozin alone has a small risk of hypoglycemia, but if used in combination with other hypoglycemic drugs, it may increase the risk of hypoglycemia. Blood sugar should be closely monitored during use to avoid over-medication.

4.Renal insufficiency: The excretion of dapagliflozin is mainly through the kidneys, so patients with renal insufficiency need to be particularly careful when using it. Your doctor may monitor kidney function before starting treatment and during treatment.

Notes:

1.Dose and time of medication: Patients should strictly follow the doctor’s recommendations and do not increase or decrease the dosage at will. Typically, dapagliflozin is taken by mouth once daily, before or after breakfast.

2.Diet and exercise: In addition to medication, diet and exercise are also very important in controlling blood sugar. Patients should follow a healthy diet, limit carbohydrate intake, and participate in moderate physical activity.

3.Fluid intake: The diuretic effect of dapagliflozin may cause increased urine, so patients should maintain adequate fluid intake during medication to prevent dehydration.

4.Kidney function monitoring: If the patient has risk factors for kidney function damage, such as older age, history of kidney disease, etc., the doctor may require regular kidney function monitoring.

5.Drug interactions: While using dapagliflozin, patients should inform their doctors about other drugs they are using to avoid possible drug interactions.

6.Pregnancy and lactation: There are currently limited studies on the safety of dapagliflozin during pregnancy and lactation. Patients should use it under the guidance of a doctor during pregnancy or lactation.

7.Surgery and special circumstances: If the patient needs surgery or needs to stop medication under special circumstances, the patient should inform the doctor in advance and follow the doctor's advice.

8.Adverse reactions: The use of dapagliflozin may cause some adverse reactions, such as urinary tract infection, hypoglycemia, fatigue, etc. If any discomfort occurs, you should consult your doctor promptly.

In short, as a treatment option for type 2 diabetes, dapagliflozin requires patients to closely follow the doctor's advice and monitoring when using it. Through reasonable medication, diet and lifestyle management, blood sugar can be effectively controlled and quality of life improved. However, you still need to be alert to possible risks and side effects during use, and communicate with medical professionals in a timely manner to ensure safe and effective treatment.

Dapagliflozin has been launched in China and has been included in medical insurance. Patients can purchase it domestically. The domestic price is relatively cheap. Please consult the local hospital pharmacy or medical insurance bureau for specific prices and reimbursement policies.